Analyst firms · Morgan Stanley · PLD
Morgan Stanley PLD price target and rating history
Prologis Inc. (PLD) · Real Estate
Morgan Stanley rates Prologis Inc. (PLD) Overweight with a $120 price target, as of its latest action on Oct 17, 2022. It has published 4 rating actions on PLD since July 2021, including 0 upgrades and 0 downgrades. Across 6 firms with a PLD price target in the last 12 months, the median target is $155.
- Current rating
- Overweight
- Price target
- $120
- Median target, all firms
- $155
- Actions on PLD
- 4
Morgan Stanley price target on PLD
Every Morgan Stanley rating on PLD
- Oct 17, 2022
- Dec 15, 2021
- Nov 22, 2021
- Jul 15, 2021
How other firms rate PLD
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Raymond James | Outperform | $163 | Oct 21, 2026 |
| Scotiabank | Sector Outperform | $150 | Oct 13, 2026 |
| RBC Capital Markets | Outperform | $160 | Aug 5, 2026 |
| BMO Capital Markets | Outperform | $162 | May 7, 2026 |
| Citigroup | Buy | $145 | Mar 5, 2026 |
| Robert W. Baird | Neutral | $130 | Jan 8, 2026 |
Questions about Morgan Stanley and PLD
- What is Morgan Stanley's price target for PLD?
- Morgan Stanley's latest stated price target for Prologis Inc. (PLD) is $120, from its action on Oct 17, 2022.
- What is Morgan Stanley's rating on PLD?
- Morgan Stanley rates PLD Overweight, a bullish rating, as of Oct 17, 2022.
- When did Morgan Stanley last change its view on PLD?
- On Oct 17, 2022, Morgan Stanley resumes coverage at Overweight, price target $120.
- How does Morgan Stanley's PLD target compare with other analysts?
- Across 6 firms with a PLD price target in the last 12 months, the median target is $155.
More PLD rating histories
- Raymond James7
- Scotiabank6
- RBC Capital Markets4
- BMO Capital Markets5
- Robert W. Baird3
- BofA Securities3
- Mizuho3
- Goldman Sachs4
- Evercore ISI3
All Morgan Stanley ratingsPLD news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.